Table 2 Univariate analyses of factors associated with OS and TTR

Gender (male vs. female)

1.375 (0.751–2.518)

0.302

1.072 (0.605–1.898)

0.811

Age (≤50 vs. >50 years)

0.863 (0.577–1.289)

0.471

1.140 (0.748–1.738)

0.542

HBsAg (negative vs. positive)

1.444 (0.788–2.646)

0.234

1.833 (0.974–3.449)

0.061

HCV (negative vs. positive)

1.157 (0.365–3.669)

0.805

0.612 (0.150–2.503)

0.494

Liver cirrhosis (no vs. yes)

1.337 (0.865–2.067)

0.192

1.476 (0.947–2.299)

0.085

AFP (≤20 vs. >20 ng/ml)

1.408 (0.893–2.219)

0.140

1.005 (0.650–1.553)

0.983

Tumor number (single vs. multiple)

1.731 (1.160–2.581)

0.007

1.877 (1.247–2.826)

0.003

Tumor size (≤5 vs. >5 cm)

2.211 (1.461–3.345)

<0.001

1.936 (1.278–2.934)

0.002

Tumor encapsulation (complete vs. incomplete)

1.566 (1.049–2.338)

0.028

1.116 (0.744–1.676)

0.595

Microvascular invasion (absent vs. present)

1.602 (1.074–2.389)

0.021

1.556 (1.033–2.345)

0.035

Edmondson grade (I–II vs. III–IV)

1.401 (0.898–2.184)

0.137

1.282 (0.826–1.990)

0.268

TNM stage (I vs. II–III)

2.117 (1.026–4.369)

0.042

3.260 (1.423–7.468)

0.005

MAGL (low vs. high)

1.856 (1.220–2.823)

0.004

2.040 (1.331–3.128)

0.001